1-9 of 9
Jack Ansell
Close
Sort by
Journal Articles

Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulants

Jack Ansell, Bryan E. Laulicht, Sasha H. Bakhru, Allison Burnett, Xuan Jiang, Lirong Chen, Christopher Baker, Stephen Villano, Solomon Steiner
Journal: Blood
Blood (2021) 137 (1): 115–125.
https://doi.org/10.1182/blood.2020007116
Published: 2021
Includes: Supplemental data
Journal Articles

Reversal of Anticoagulation By Ciraparantag: Time to Onset and Duration of Effect

Jack Ansell, MD, Bryan Laulicht, PhD, Sasha Bakhru, PhD, Xiaohui Luo, PhD, Stephen Villano, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24.
https://doi.org/10.1182/blood-2020-140524
Published: 2020
Journal Articles

Ciraparantag Safely and Effectively Reverses Apixaban and Rivaroxaban in Age-Matched Healthy Volunteers As Measured By Whole Blood Clotting Time

Bryan Laulicht, PhD, Sasha Bakhru, PhD, Solomon Steiner, PhD, Jack Ansell, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 987.
https://doi.org/10.1182/blood-2018-99-116754
Published: 2018
Journal Articles

Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures

Clinical Trials & Observations
David Garcia, John H. Alexander, Lars Wallentin, Daniel M. Wojdyla, Laine Thomas, Michael Hanna, Sana M. Al-Khatib, Paul Dorian, Jack Ansell, Patrick Commerford, Greg Flaker, Fernando Lanas, Dragos Vinereanu, Denis Xavier, Elaine M. Hylek, Claes Held, Freek W. A. Verheugt, Christopher B. Granger, Renato D. Lopes
Journal: Blood
Blood (2014) 124 (25): 3692–3698.
https://doi.org/10.1182/blood-2014-08-595496
Published: 2014
Journal Articles

Indirect Comparison Of Dabigatran, Rivaroxaban and Apixaban For Venous Thromboembolic Disease

Simon Mantha, MD, MPH, Jack Ansell, MD
Journal: Blood
Blood (2013) 122 (21): 3640.
https://doi.org/10.1182/blood.V122.21.3640.3640
Published: 2013
Journal Articles

Indications for Inferior Vena Cava (IVC) Filter Placement - Assessing Compliance with Accepted Standards Set by Two Professional Societies

Amanjit S. Baadh, MD, Stephen Rivoli, MPH, MA, CPHQ, Jack Ansell, MD, Robert E. Graham, MD, MPH
Journal: Blood
Blood (2010) 116 (21): 2553.
https://doi.org/10.1182/blood.V116.21.2553.2553
Published: 2010
Journal Articles

Anticoagulant Management of Atrial Fibrillation In the United States: Findings From a Large National Database of Clinical Test Results (Quest Diagnostics Health Trends™ Report).

Jeffrey S. Dlott, MD, Roberta George, MS, Xiaohua Huang, MS, Muneer Odeh, MS, Harvey W. Kaufman, MD, Elaine M. Hylek, MD, MPH, Jack Ansell, MD
Journal: Blood
Blood (2010) 116 (21): 1103.
https://doi.org/10.1182/blood.V116.21.1103.1103
Published: 2010
Journal Articles

A Phase II Randomized, Double-Blind, Eight-Arm, Parallel-Group, Dose-Response Study of Apixaban, a New Oral Factor Xa Inhibitor for the Prevention of Deep Vein Thrombosis in Knee Replacement Surgery - On Behalf of the Apixaban Investigators.

Michael R. Lassen, MD, Bruce L. Davidson, MD, Alexander Gallus, MD, Graham Pineo, MD, Jack Ansell, MD, David Deitchman, PhD
Journal: Blood
Blood (2006) 108 (11): 574.
https://doi.org/10.1182/blood.V108.11.574.574
Published: 2006
Journal Articles

A Randomized, Double-Blind Trial of the Interaction between Cranberry Juice and Warfarin.

Jack Ansell, MD, Maryellen McDonough, RN, Jerold S. Harmatz, David J. Greenblatt, MD
Journal: Blood
Blood (2006) 108 (11): 4125.
https://doi.org/10.1182/blood.V108.11.4125.4125
Published: 2006